Paper31979032
Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal.
Costa-de-Oliveira S and 1 other. Microorganisms, 2020. Cited by 151 papers, by iCite.
Cite this record
ConductScience Library. Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal. Papers, record 31979032. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31979032
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References170
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17660216 | Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. | Ann Rheum Dis | 2008 | https://conductscience.org/library/papers/17660216 | PubMed |
| 2 | 12753189 | Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. | Mol Microbiol | 2003 | https://conductscience.org/library/papers/12753189 | PubMed |
| 3 | 30348662 | FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30348662 | PubMed |
| 4 | 19109335 | Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus. | J Antimicrob Chemother | 2009 | https://conductscience.org/library/papers/19109335 | PubMed |
| 5 | 19656781 | The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility. | J Antimicrob Chemother | 2009 | https://conductscience.org/library/papers/19656781 | PubMed |
| 6 | 24668706 | Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. | Eur Rev Med Pharmacol Sci | 2014 | https://conductscience.org/library/papers/24668706 | PubMed |
| 7 | 10543759 | The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10543759 | PubMed |
| 8 | 17569573 | Resistance to echinocandin-class antifungal drugs. | Drug Resist Updat | 2007 | https://conductscience.org/library/papers/17569573 | PubMed |
| 9 | 26567280 | Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/26567280 | PubMed |
| 10 | 24270071 | Epidemiology of candidaemia and invasive candidiasis. A changing face. | Rev Iberoam Micol | 2014 | https://conductscience.org/library/papers/24270071 | PubMed |
| 11 | 29304214 | Biofilms and beyond: expanding echinocandin utility. | J Antimicrob Chemother | 2018 | https://conductscience.org/library/papers/29304214 | PubMed |
| 12 | 9037636 | Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. | Intensive Care Med | 1997 | https://conductscience.org/library/papers/9037636 | PubMed |
| 13 | 21307753 | Candidemia in burn patients: figures and facts. | J Trauma | 2011 | https://conductscience.org/library/papers/21307753 | PubMed |
| 14 | 7541044 | Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7541044 | PubMed |
| 15 | 17983269 | The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. | PLoS Pathog | 2007 | https://conductscience.org/library/papers/17983269 | PubMed |
| 16 | 23740727 | In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds. | J Clin Microbiol | 2013 | https://conductscience.org/library/papers/23740727 | PubMed |
| 17 | 22203603 | Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22203603 | PubMed |
| 18 | 30895218 | Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/30895218 | PubMed |
| 19 | 19191635 | Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | Clin Infect Dis | 2009 | https://conductscience.org/library/papers/19191635 | PubMed |
| 20 | 19541532 | Hidden killers: persistence of opportunistic fungal pathogens in the human host. | Curr Opin Microbiol | 2009 | https://conductscience.org/library/papers/19541532 | PubMed |
Cited by110
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930756 | Adapting to the Host: Physiological Responses, Cell Wall Remodeling, and Persistence in Non-albicans Candida Species. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42930756 | PubMed |
| 42920537 | Phenotypic and metabolic characterization of an ADH2 deletion mutant associated with reduced fluconazole susceptibility in Candida albicans. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42920537 | PubMed |
| 42902047 | Assessment of Candida attributes under in vitro repeated exposure to hydrogen peroxide. | Int Microbiol | 2026 | https://conductscience.org/library/papers/42902047 | PubMed |
| 42807021 | Large-scale virtual screening of 17,967 IMPPAT phytochemicals identifies multiple CDR1 binders and reveals Apigenin-7-O-glucuronide as a putative CDR1-GSC1 dual-target lead against Candida albicans with initial in-vitro evidence. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42807021 | PubMed |
| 42794569 | WHO Critical Priority Fungi: A Comprehensive Review of Antifungal Resistance, Emerging Therapeutic Strategies, and the Potential of Antifungal Peptides. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794569 | PubMed |
| 42707095 | Microbial community structure in tinea corporis and antifungal activity of Lactiplantibacillus plantarum YM-4-3 strain. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42707095 | PubMed |
| 42598379 | First Case of Candidemia With Fluconazole-Resistant Candida albicans and Y132H Mutations in ERG11 Gene From Pakistan. | Case Rep Infect Dis | 2026 | https://conductscience.org/library/papers/42598379 | PubMed |
| 42471448 | Synthetic Cinnamyl Acetate as a Candidate Inhibitor of Candida albicans Biofilms with an Adhesin-Associated Anti-Adhesion Phenotype: Evidence from Molecular Docking and Antifungal Assays. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42471448 | PubMed |
| 42436744 | In Vivo Evaluation of Efficacy and Toxicity of Bioinspired Peptides With Antimicrobial Properties Against Fungal Infection in Galleria mellonella Larvae. | Int J Microbiol | 2026 | https://conductscience.org/library/papers/42436744 | PubMed |
| 42409910 | In vitro evaluation of Curcuma longa extract for antifungal, antibiofilm, and synergistic activity against Candida spp. | Sci Rep | 2026 | https://conductscience.org/library/papers/42409910 | PubMed |
| 42205484 | In silico identification of isosilybin a targeting squalene epoxidase as an antifungal adjuvant with in vitro validation against azole-resistant Candida and emerging yeasts. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42205484 | PubMed |
| 42197494 | Infectious Spondylodiscitis of Bacterial Causes in Adults: Epidemiology, Pathophysiology, Diagnostic and Treatment Challenges. | Microorganisms | 2026 | https://conductscience.org/library/papers/42197494 | PubMed |
| 42015072 | Candida urinary tract infections, antifungal susceptibility and factors associated with candiduria among pregnant women seeking antenatal care at Murang'a County Referral Hospital, Kenya. | BMC Pregnancy Childbirth | 2026 | https://conductscience.org/library/papers/42015072 | PubMed |
| 41813782 | Povidone iodine demonstrates strong efficacy in reducing Candida biofilm in an in vitro fungal prosthetic infection. | Sci Rep | 2026 | https://conductscience.org/library/papers/41813782 | PubMed |
| 41696452 | Caspofungin enhances antifungal immunity in human blood through transcriptional reprogramming. | Microlife | 2026 | https://conductscience.org/library/papers/41696452 | PubMed |
| 41688542 | Candida albicans infection suppresses lipopolysaccharide or Pseudomonas aeruginosa stimulated murine bone marrow derived macrophage (BMDM) responses. | Sci Rep | 2026 | https://conductscience.org/library/papers/41688542 | PubMed |
| 41596273 | Catechin Augments the Antifungal Efficacy of Fluconazole Against Candida parapsilosis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596273 | PubMed |
| 41573869 | An optimized protocol for Candida albicans infection in Schmidtea mediterranea to study fungal pathogenesis and host defense. | bioRxiv | 2025 | https://conductscience.org/library/papers/41573869 | PubMed |
| 41471177 | Epidemiology of Fungal Bloodstream Infections and Antifungal Susceptibility in a Tertiary Care Hospital in Riyadh, Saudi Arabia: A Rare Candida Co-Infection Case. | Pathogens | 2025 | https://conductscience.org/library/papers/41471177 | PubMed |
| 41355988 | Overcoming antifungal resistance in Candida albicans via RNA interference: a therapeutic perspective. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41355988 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| CYP51A1 | 1595 | PubTator's text mining | https://conductscience.org/library/genes/1595 | NCBI Gene |
| PGP | 283871 | PubTator's text mining | https://conductscience.org/library/genes/283871 | NCBI Gene |
| PPP3R1 | 5534 | PubTator's text mining | https://conductscience.org/library/genes/5534 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31979032
GET https://conductscience.org/api/papers/v1/31979032/references?page=2